Fibrin Sealant (Tisseel) used in the Experimental Arm.
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Malignant Melanoma
Conditions
Malignant Melanoma, Carcinoma, Squamous Cell
Trial Timeline
Jan 1, 2003 โ Jun 1, 2010
NCT ID
NCT00324272About Fibrin Sealant (Tisseel) used in the Experimental Arm.
Fibrin Sealant (Tisseel) used in the Experimental Arm. is a approved stage product being developed by Baxter for Malignant Melanoma. The current trial status is completed. This product is registered under clinical trial identifier NCT00324272. Target conditions include Malignant Melanoma, Carcinoma, Squamous Cell.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00324272 | Approved | Completed |
Competing Products
20 competing products in Malignant Melanoma